Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life.
We employ rigorous science
to pioneer the discovery and clinical development of the next generation of naturally derived bioactives, starting with Mitopure™ (a proprietary highly pure Urolithin A). Our focus is the development of innovative products designed to meet the health needs of an aging population. Our current work builds on modulating Mitochondrial function.
We are improving muscle health
Our most advanced product targets the reversal of age-related muscle decline by improving the activity of mitochondria – the “powerhouse of the cell” – to optimize muscle function.
Society is aging. Worldwide,
it’s projected there will be more than 1 billion people over 65 years old by 2030.
A decline in skeletal muscle strength and overall function is a hallmark of aging. These changes can become debilitating and lead to a condition called sarcopenia, which is thought to affect 30% of elderly.
We are targeting a novel pathway
Our lead bioactive - a metabolite of pomegranates - has been demonstrated to trigger a highly effective biological mechanism of action that recycles and rejuvenates aging mitochondria via a process called mitophagy.
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos
Amazentis l Press Release l January 23rd 2020
First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB
Amazentis l Press Release l June 14th 2019
Amazentis SA Announces Completion of Series C Financing
Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America
Amazentis l Press Release l March 21st 2018
Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A
Amazentis l Press Release l April 27th 2017
Pomegranates reveal its powerful anti-aging secret
EPFL l Video l July 6th 2016
In the media
Pomegranate compound with anti-aging effects passes human trial
medicalxpress l Published online l June 17th 2019
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
Nature Metabolism l Published online l June 14th 2019
Nestle Deal Seeks to Tap Pomegranate's Anti-Aging Potential
Bloomberg l Published online l April 2nd 2019
Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents
Nature Medicine l Published online l July 11th 2016
New Scientist l Published online l July 11th 2016
Medical News Today l Published online l July 11th 2016
Telegraph l Published online l July 11th 2016
Bilan l Published online l July 11th 2016
Financial Times l Published online l July 12th 2016